New Treatment For Actinic Keratosis Now Available In The UK
A new treatment for sun-damaged skin that can lead to skin cancer was launched recently by LEO Pharma. Picato® (ingenol mebutate) gel is a topical treatment licensed for the cutaneous treatment of non- hyperkeratotic, non-hypertrophic actinic keratosis (AK) in adults, a type of skin damage caused by long-term sun, or UV exposure, that has the potential to progress to the non-melanoma skin cancer, squamous cell carcinoma (SCC)...
Source: Health News from Medical News Today - Category: Consumer Health News Tags: Dermatology Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Dermatology | Health | Melanoma | Nonmelanoma Skin Cancer | Pharmaceuticals | Skin | Skin Cancer | Squamous Cell Carcinoma